课题基金 / 基金详情

Investigating monocyte dysfunction in Down Syndrome

Investigating monocyte dysfunction in Down Syndrome
研究唐氏综合症的单核细胞功能障碍
批准号:
10854106
负责人:
Betsy J Barnes
金额:
$38.37万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-24 至 2024-06-30

项目摘要

项目成果

Betsy J Barnes的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY We are requesting an Administrative Supplement for the INCLUDE Project for R01 AR076242 “IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis”. The proposed studies for the in this Supplement are within the scope of the active parent grant, focused on Down syndrome (DS) and are aligned with the goals of the overall INCLUDE Project—Component 1: Targeted high risk – high reward basic science studies highly relevant to DS. Our studies take advantage of a growing registry and biorepository of DS individuals that has been established at the Benaroya Research Institute by Drs. Bernard Khor and Jane Buckner. The objectives of this administrative supplement are to better understand innate immune alterations in DS. Individuals with DS have immune dysfunction evidenced by decreased vaccine responses, increased severity of viral infections and increased incidence of certain autoimmune diseases, including autoimmune thyroiditis, type 1 diabetes and juvenile idiopathic arthritis (JIA). DS individuals also have increased type 1 IFN responses and increased amounts of some inflammatory cytokines and specific alterations in T and B cells. However, how these alterations lead to the overall changes in immunity in DS is not well-understood. Importantly, there has been much focus on adaptive immune responses in DS, with less focus on cells of the innate immune system, including monocytes and macrophages, important in the pathogenesis of many autoimmune diseases, including (JIA). This supplement is within the scope of the Parent R01 as it: 1) investigates monocytes and TLR responses in these cells, which are the focus of the parent R01, 2) relates to a form of juvenile arthritis seen more frequently in individuals with DS, as the parent grant focuses on another form of juvenile arthritis (systemic juvenile idiopathic arthritis (SJIA)), and 3) will leverage our existing single cell RNA-Seq (scRNA-Seq) data funded by the parent R01. Data generated from this supplement will inform our parent R01 by giving us additional monocyte scRNA-Seq datasets to compare with our already generated scRNA-Seq datasets from children with SJIA-associated MAS and matched controls. This supplement is within NIAMS INCLUDE Program priorities to better understand arthritic disorders in DS across the lifepan. Because monocytes and macrophages are key players in pathogenesis of all forms of arthritis, understanding whether these cells and their responses are dysregulated in DS will lead to a better understanding of their contributions to the increased incidence of arthritis in children with DS.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fimmu.2022.951254
发表时间: 2022
期刊: FRONTIERS IN IMMUNOLOGY
影响因子: 7.3
作者: [Matta, Bharati, Battaglia, Jenna, Barnes, Betsy J.]
通讯作者: Barnes, Betsy J.
DOI: 10.1002/art.41677
发表时间: 2021-08
期刊: Arthritis & rheumatology (Hoboken, N.J.)
影响因子: --
作者: [Lu A, Wu S, Niu J, Cui M, Chen M, Clapp WL, Barnes BJ, Meng G]
通讯作者: Meng G
Implications for Speckled proteins 110 and 140 in adaptive immunity
New role(s) for IRF5 as a regulator of tau accumulation in Alzheimer’s disease
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis
海外基金